Sign up
Healthed-White-on-Blue
Myfanwy Graham

Myfanwy Graham

Myfanwy Graham (M.Pharm, MPS) is an NHMRC Postgraduate Scholar and Monash Research Excellence Scholar at the Monash Addiction Research Centre in Melbourne, Fulbright Scholar Alumna in Public Health Policy (medicinal cannabis) and USC Schaeffer Institute Scholar, USC Leonard D. Schaeffer Institute for Public Policy & Government Service, University of Southern California. Myfanwy has been a registered pharmacist for over 17 years.Her research focuses on the impact of drug policy on public health outcomes, the translation of research findings into clinical practice settings, and the use of real-world data to inform future policy decisions. She has completed consultancy work for the United Nations Office on Drugs and Crime, the World Health Organization and the National Academy of Sciences, Engineering and Medicine.Prior to the award of a prestigious Fulbright Scholar role, Myfanwy was an Associate Investigator of the NHMRC-funded Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), was the Principal Medicines Information Pharmacist of a state government-funded medicinal cannabis advisory service (2018-2022) and developed state government-funded medicinal cannabis prescribing guidance documents.

More from this expert

Hemp,Oil,Cbd,,Cannabis,Herb,And,Leaves,For,Treatment,,Extract

More people are trying medicinal cannabis for chronic pain

Medicinal cannabis refers to legally prescribed cannabis products. These are either the plant itself, or naturally occurring ingredients extracted from the plant.

By A/Prof Suzanne Nielsen, Myfanwy Graham
Clinical Articles iconClinical Articles

Discover

Healthed

CPD platform

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Register for webcast